Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $19.57, along with a high estimate of $51.00 and a low estimate of $10.35. A 38.75% drop is ...

Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by the strength of t:slim X2 based on Control-IQ technology and new product launches. In the first quarter, the ...

Truist analyst Richard Newitter raised the firm’s price target on Tandem Diabetes (TNDM) to $16 from $14 and keeps a Hold rating on the shares as ...

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5% in the morning session after the company announced the publication of a study showing its automated insulin delivery ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today presented new real-world insights from a survey on Tandem Mobi ...

Tandem Diabetes delivered weaker-than-expected Q4 results but followed with strong forward guidance. The company launched four new products in the U.S. last quarter. For its fourth quarter of 2023, ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collaboration agreement ...

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors To Inquire About Securities Class Action Investigation - TNDM. NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global ...

Tandem Diabetes TNDM is gaining from continued product innovations. Yet, ongoing macroeconomic challenges and tough competition pose challenges. The stock carries a Zacks Rank #3 (Hold) currently.

Tandem Diabetes Care's iOS app and insulin pump has made more than 100 people need medical care, resulting in two hospitalizations this year so far. Tandem Diabetes recalled 85,863 devices in May and ...

Tandem Diabetes Care, Inc. TNDM is well poised for growth in the coming months, backed by strong domestic and international pump sales along with robust domestic and international pump shipments.